Sweep 2 Flashcards
• Familial Hypercholesterolemia- Treatment-
Iomitapide
• Phenylketonuria- ———– disorder that affects 1 in 10,000 Caucasian infants. Severe lack of ————–, leading to —————. Affected infants are normal at birth, but elevated phenylalanine levels impair brain development, and mental retardation is evident by 6 months of age.
Autosomal recessive
phenylalanine hydroxylase
hyperphenylalaninemia and PKU
• Lysosomal Storage Diseases- ——————— transmission. Commonly affect infants and young children. Accumulation of —————— in —————— with ——————- Frequent ——- involvement, mental retardation and/or early death
Autosomal recessive
insoluble large molecules (sphingolipids and mucopolysaccharides)
macrophages
hepatosplenomegaly
CNS
Aspirin: major injury is
metabolic one – first there is respiratory alkalosis followed by metabolic acidosis. It may progress to seizures and coma.
• Organ system changes radiation-
o Hematopoietic, lymphoid-
Lymph nodes and spleen shrink in size. Granulocytes decrease over 1-2 wks and rebound in 2-3 months, pts are susceptible to infections at this time!
• Aggregation- Release of ———– into the local milieu causes activation of ————— mediated through ————–
cytoplasmic ADP
adjacent platelets, and platelet-platelet binding
fibrinogen and the gp IIb/IIIa receptor.
• Fibrin clot- formed when fibrin monomers generated by
thrombin polymerize
Fibrin clot: o Stabilization of fibrin monomers by
factor XIII
o Antithrombin II in presence of heparin→
complex with thrombin
Antithrombin II • Destroys ability of ———– to participate in generation of ———- monomers
thrombin
fibrin
• Protein C System- regulation of factors ————-
Va and VIIIa
o Protein C or S deficiencies result in ————— states
hypercoagulable
• Fibrinolysis- limits generation of
fibrin clot
Fibrinolysis: o Tissue plasminogen activator in presence of fibrin
• Leads to conversion of ————-
o Uncontrolled activation of plasmin→ ————
plasminogen→plasmin
fibrinogenolysis
Disorders of primary hemostasis-
o Clinical manifestations-
mucocutaneous bleeding, trauma associated bleeding
Disorders of primary hemostasis:
o Lab manifestations-
prolonged bleeding time and thrombocytopenia
• Disorders of secondary hemostasis-
o Clinical manifestations-
soft tissue bleeding, trauma associated bleeding
• Disorders of secondary hemostasis-
o Lab manifestations-
prolonged PT and/or PTT and/or thrombin time
• Disorders of regulatory system-
o Clinical manifestations-
soft tissue bleeding, trauma associated bleeding
Disorders of reg system:
o Lab manifestations-
normal
• Thombocytopenia- ———– in platelet count. Spontaneous bleeding may not become manifest until count ————-. o
decrease
falls below 20,000
Thrombocytopenia:
Clinically-
petechial hemorrhages in skin and mucous membranes
Thrombocytopenia:
o Lab
- peripheral blood smear morphology, platelet antibody tests also helpful
• Immune Thrombocytopenic Purpura (ITP)-
o Clinically-
petechial hemorrhage, bruising, gingival bleeding
• Immune Thrombocytopenic Purpura (ITP)-
o Lab-
bone marrow reveals megakaryocytes normal or increased
• Immune Thrombocytopenic Purpura (ITP)-
o Therapy-
acute often self-limited 2-6 weeks, corticosteroids (suppress antibody formation), IV immunoglobulin, and splenectomy
o Ex. Hemolytic transfusion reaction- decrease in ———— leads to ———— excretion in urine.
serum haptoglobin
hemoglobin
Hemoglobin is toxic to kidney leading to —————
hyperbilirubinemia and jaundice
• Vitamin B12 and Folate deficiency- ————– Anemia; need these to make ———–, deficiency leads to delay in mitotic division, nuclear size increases, end result is huge red cell precursor (megaloblast).
Megaloblastic
thymidine